CA2418399A1 - Non-invasive system for the determination of analytes in body fluids - Google Patents
Non-invasive system for the determination of analytes in body fluids Download PDFInfo
- Publication number
- CA2418399A1 CA2418399A1 CA002418399A CA2418399A CA2418399A1 CA 2418399 A1 CA2418399 A1 CA 2418399A1 CA 002418399 A CA002418399 A CA 002418399A CA 2418399 A CA2418399 A CA 2418399A CA 2418399 A1 CA2418399 A1 CA 2418399A1
- Authority
- CA
- Canada
- Prior art keywords
- body tissue
- light
- infrared light
- glucose
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000001124 body fluid Anatomy 0.000 title claims abstract description 55
- 239000010839 body fluid Substances 0.000 title claims abstract description 55
- 230000003595 spectral effect Effects 0.000 claims abstract description 101
- 238000004422 calculation algorithm Methods 0.000 claims abstract description 43
- 239000012491 analyte Substances 0.000 claims abstract description 28
- 238000012545 processing Methods 0.000 claims abstract description 12
- 229960001031 glucose Drugs 0.000 claims description 133
- 239000008103 glucose Substances 0.000 claims description 133
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 132
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 126
- 210000001519 tissue Anatomy 0.000 claims description 112
- 235000001727 glucose Nutrition 0.000 claims description 111
- 238000012360 testing method Methods 0.000 claims description 68
- 238000000034 method Methods 0.000 claims description 62
- 239000000835 fiber Substances 0.000 claims description 37
- 238000004458 analytical method Methods 0.000 claims description 30
- 229910052594 sapphire Inorganic materials 0.000 claims description 22
- 239000010980 sapphire Substances 0.000 claims description 22
- 230000003287 optical effect Effects 0.000 claims description 19
- 238000001914 filtration Methods 0.000 claims description 8
- 238000010238 partial least squares regression Methods 0.000 claims description 8
- 210000003722 extracellular fluid Anatomy 0.000 claims description 7
- 230000002068 genetic effect Effects 0.000 claims description 7
- 238000012937 correction Methods 0.000 claims description 6
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 6
- DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical compound [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 claims description 5
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 claims description 5
- 229940000489 arsenate Drugs 0.000 claims description 5
- KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 claims description 5
- 229910052733 gallium Inorganic materials 0.000 claims description 5
- 229910052738 indium Inorganic materials 0.000 claims description 5
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 claims description 2
- 238000002474 experimental method Methods 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims 4
- 210000002977 intracellular fluid Anatomy 0.000 claims 3
- 239000000306 component Substances 0.000 claims 2
- 238000013480 data collection Methods 0.000 claims 2
- 239000012510 hollow fiber Substances 0.000 claims 1
- 230000000875 corresponding effect Effects 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 53
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 28
- 239000013078 crystal Substances 0.000 description 15
- 238000001228 spectrum Methods 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 230000005540 biological transmission Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 6
- 210000003811 finger Anatomy 0.000 description 5
- 238000009499 grossing Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 229910000673 Indium arsenide Inorganic materials 0.000 description 2
- 208000034693 Laceration Diseases 0.000 description 2
- 229910000661 Mercury cadmium telluride Inorganic materials 0.000 description 2
- 208000036366 Sensation of pressure Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 238000002790 cross-validation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- RPQDHPTXJYYUPQ-UHFFFAOYSA-N indium arsenide Chemical compound [In]#[As] RPQDHPTXJYYUPQ-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000007781 pre-processing Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 229910000530 Gallium indium arsenide Inorganic materials 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MCMSPRNYOJJPIZ-UHFFFAOYSA-N cadmium;mercury;tellurium Chemical compound [Cd]=[Te]=[Hg] MCMSPRNYOJJPIZ-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- AKUCEXGLFUSJCD-UHFFFAOYSA-N indium(3+);selenium(2-) Chemical compound [Se-2].[Se-2].[Se-2].[In+3].[In+3] AKUCEXGLFUSJCD-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940056932 lead sulfide Drugs 0.000 description 1
- 229910052981 lead sulfide Inorganic materials 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- LAJZODKXOMJMPK-UHFFFAOYSA-N tellurium dioxide Chemical compound O=[Te]=O LAJZODKXOMJMPK-UHFFFAOYSA-N 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7253—Details of waveform analysis characterised by using transforms
- A61B5/726—Details of waveform analysis characterised by using transforms using Wavelet transforms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
- G01N21/274—Calibration, base line adjustment, drift correction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/067—Electro-optic, magneto-optic, acousto-optic elements
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35535802P | 2002-02-11 | 2002-02-11 | |
| US60/355,358 | 2002-02-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2418399A1 true CA2418399A1 (en) | 2003-08-11 |
Family
ID=27613551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002418399A Abandoned CA2418399A1 (en) | 2002-02-11 | 2003-02-04 | Non-invasive system for the determination of analytes in body fluids |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US7299079B2 (enExample) |
| EP (2) | EP2400288A1 (enExample) |
| JP (1) | JP4476552B2 (enExample) |
| AU (1) | AU2003200359A1 (enExample) |
| CA (1) | CA2418399A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114206215A (zh) * | 2019-06-12 | 2022-03-18 | 汽车交通安全联合公司 | 用于车辆驾驶员中分析物的非侵入性测量的系统 |
Families Citing this family (149)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
| US6949816B2 (en) * | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
| US6522903B1 (en) | 2000-10-19 | 2003-02-18 | Medoptix, Inc. | Glucose measurement utilizing non-invasive assessment methods |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
| US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| AU2002315177A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| AU2002315180A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Electric lancet actuator |
| CA2418399A1 (en) | 2002-02-11 | 2003-08-11 | Bayer Healthcare, Llc | Non-invasive system for the determination of analytes in body fluids |
| US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
| US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7198606B2 (en) | 2002-04-19 | 2007-04-03 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
| US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
| US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| CN100406872C (zh) * | 2002-11-04 | 2008-07-30 | 天津市先石光学技术有限公司 | 复合光谱测量方法及其光谱检测仪器 |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| US7153256B2 (en) | 2003-03-07 | 2006-12-26 | Neuronetics, Inc. | Reducing discomfort caused by electrical stimulation |
| US8118722B2 (en) | 2003-03-07 | 2012-02-21 | Neuronetics, Inc. | Reducing discomfort caused by electrical stimulation |
| KR100464324B1 (ko) * | 2003-03-17 | 2005-01-03 | 삼성전자주식회사 | 목적물의 성분농도 측정방법 및 장치 |
| EP1628567B1 (en) | 2003-05-30 | 2010-08-04 | Pelikan Technologies Inc. | Method and apparatus for fluid injection |
| ES2490740T3 (es) | 2003-06-06 | 2014-09-04 | Sanofi-Aventis Deutschland Gmbh | Aparato para toma de muestras de fluido sanguíneo y detección de analitos |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | METHOD AND APPARATUS FOR PROVIDING IMPROVED SAMPLE CAPTURING DEVICE |
| US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
| JP2005192611A (ja) * | 2003-12-26 | 2005-07-21 | Olympus Corp | グルコース濃度測定装置 |
| US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
| US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
| US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
| US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
| EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | METHOD AND DEVICE FOR A LIQUID DETECTION DEVICE |
| US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
| US7287831B2 (en) * | 2005-02-28 | 2007-10-30 | Silverbrook Research Pty Ltd | Printhead integrated circuit adapted for adhesive bonding |
| US7468284B2 (en) * | 2005-02-28 | 2008-12-23 | Silverbrook Research Pty Ltd | Method of bonding substrates |
| WO2006089337A1 (en) * | 2005-02-28 | 2006-08-31 | Silverbrook Research Pty Ltd | Method of bonding substrates |
| US7425052B2 (en) * | 2005-02-28 | 2008-09-16 | Silverbrook Research Pty Ltd | Printhead assembly having improved adhesive bond strength |
| US7372145B2 (en) * | 2005-02-28 | 2008-05-13 | Silverbrook Research Pty Ltd | Bonded assembly having improved adhesive bond strength |
| US7341330B2 (en) | 2005-02-28 | 2008-03-11 | Silverbrook Research Pty Ltd | Substrates adapted for adhesive bonding |
| JP5001934B2 (ja) * | 2005-04-15 | 2012-08-15 | バイエル・ヘルスケア・エルエルシー | 体内グルコースを測定する非侵襲的システム及び方法 |
| GB0606891D0 (en) * | 2006-04-05 | 2006-05-17 | Council Cent Lab Res Councils | Raman Analysis Of Pharmaceutical Tablets |
| JP3992064B2 (ja) * | 2006-01-20 | 2007-10-17 | 住友電気工業株式会社 | 光学分析装置 |
| JP4928849B2 (ja) * | 2006-06-27 | 2012-05-09 | 東芝メディカルシステムズ株式会社 | 非侵襲的測定装置 |
| US7973925B2 (en) * | 2007-02-06 | 2011-07-05 | C8 Medisensors Inc. | Apparatus for stabilizing mechanical, thermal, and optical properties and for reducing the fluorescence of biological samples for optical evaluation |
| US7782191B2 (en) * | 2007-07-25 | 2010-08-24 | Tomas Flores | Portable alarm apparatus for warning persons |
| EP3192876A1 (en) | 2007-10-10 | 2017-07-19 | Pocared Diagnostics Ltd. | System for conducting the identification of bacteria in urine |
| CN110967298A (zh) * | 2008-02-05 | 2020-04-07 | 普凯尔德诊断技术有限公司 | 用于鉴定生物样品中细菌的系统 |
| JP4914388B2 (ja) * | 2008-03-07 | 2012-04-11 | 日本電信電話株式会社 | 成分濃度測定装置 |
| EP2265324B1 (en) | 2008-04-11 | 2015-01-28 | Sanofi-Aventis Deutschland GmbH | Integrated analyte measurement system |
| WO2010014963A2 (en) * | 2008-07-31 | 2010-02-04 | Government Of The United States As Represented By The Secretary Of The Army | Universal models for predicting glucose concentration in humans |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| US8309897B2 (en) | 2009-02-06 | 2012-11-13 | Pocared Diagnostics Ltd. | Optical measurement arrangement |
| US10288632B2 (en) * | 2009-09-21 | 2019-05-14 | Pocared Diagnostics Ltd. | System for conducting the identification of bacteria in biological samples |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US20110313680A1 (en) * | 2010-06-22 | 2011-12-22 | Doyle Iii Francis J | Health Monitoring System |
| US8804114B2 (en) | 2010-11-03 | 2014-08-12 | Pocared Diagnostics Ltd. | Optical cup |
| US8411265B2 (en) | 2011-06-14 | 2013-04-02 | C8 Medisensors Inc. | Apparatus for stabilizing mechanical, thermal, and optical properties and for reducing the fluorescence of biological samples for optical evaluation |
| JP5426644B2 (ja) * | 2011-12-06 | 2014-02-26 | 東芝メディカルシステムズ株式会社 | 非侵襲的測定装置 |
| US9351671B2 (en) | 2012-07-16 | 2016-05-31 | Timothy Ruchti | Multiplexed pathlength resolved noninvasive analyzer apparatus and method of use thereof |
| US9351672B2 (en) | 2012-07-16 | 2016-05-31 | Timothy Ruchti | Multiplexed pathlength resolved noninvasive analyzer apparatus with stacked filters and method of use thereof |
| US20150018646A1 (en) * | 2013-07-12 | 2015-01-15 | Sandeep Gulati | Dynamic sample mapping noninvasive analyzer apparatus and method of use thereof |
| US9585604B2 (en) * | 2012-07-16 | 2017-03-07 | Zyomed Corp. | Multiplexed pathlength resolved noninvasive analyzer apparatus with dynamic optical paths and method of use thereof |
| US9065554B2 (en) * | 2012-08-01 | 2015-06-23 | Comcast Cable Communications, Llc | System and method for analyzing a network |
| US20140058224A1 (en) * | 2012-08-21 | 2014-02-27 | Opticks, Inc. | Systems and methods for detection of carotenoid-related compounds in biological tissue |
| US10067054B2 (en) | 2012-10-16 | 2018-09-04 | K Sciences Gp, Llc | Simple sugar concentration sensor and method |
| US8743355B2 (en) | 2012-10-16 | 2014-06-03 | K Sciences Gp, Llc | Simple sugar concentration sensor and method |
| JP6279609B2 (ja) | 2012-12-11 | 2018-02-14 | ポカード・ディアグノスティクス・リミテッドＰｏｃａｒｅｄ Ｄｉａｇｎｏｓｔｉｃｓ， Ｌｔｄ． | 湾曲底部を備える光学カップ |
| US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| US10395134B2 (en) * | 2013-07-26 | 2019-08-27 | University Of Utah Research Foundation | Extraction of spectral information |
| GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
| DE102014108424B3 (de) | 2014-06-16 | 2015-06-11 | Johann Wolfgang Goethe-Universität | Nicht-invasive Stoffanalyse |
| CN104200090B (zh) * | 2014-08-27 | 2017-07-14 | 百度在线网络技术（北京）有限公司 | 基于多源异构数据的预测方法和装置 |
| WO2016054079A1 (en) | 2014-09-29 | 2016-04-07 | Zyomed Corp. | Systems and methods for blood glucose and other analyte detection and measurement using collision computing |
| WO2016069909A1 (en) * | 2014-10-29 | 2016-05-06 | Zoll Medical Corporation | Transesophageal or transtracheal cardiac monitoring by optical spectroscopy |
| CN111905188B (zh) | 2015-02-18 | 2022-07-22 | 英赛罗公司 | 流体输送和输注装置及其使用方法 |
| CA2978674C (en) | 2015-03-05 | 2021-02-09 | Synaptive Medical (Barbados) Inc. | An optical coherence tomography system including a planarizing transparent material |
| CN105319181A (zh) * | 2015-11-02 | 2016-02-10 | 南京航空航天大学 | 一种生物组织热损伤参数的测定方法 |
| US11426100B1 (en) | 2015-12-08 | 2022-08-30 | Socrates Health Solutions, Inc. | Blood glucose trend meter |
| CN108369182B (zh) | 2015-12-09 | 2021-10-15 | 迪亚蒙泰克股份有限公司 | 用于分析材料的装置和方法 |
| KR102591540B1 (ko) | 2015-12-09 | 2023-10-18 | 디아몬테크 아게 | 재료 분석을 위한 장치 및 방법 |
| HK1257246A1 (zh) | 2016-01-13 | 2019-10-18 | Bigfoot Biomedical, Inc. | 糖尿病管理系统的用户界面 |
| WO2017123703A2 (en) | 2016-01-14 | 2017-07-20 | Bigfoot Biomedical, Inc. | Occlusion resolution in medication delivery devices, systems, and methods |
| CN112933333B (zh) | 2016-01-14 | 2023-03-28 | 比格福特生物医药公司 | 调整胰岛素输送速率 |
| US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
| US12383166B2 (en) | 2016-05-23 | 2025-08-12 | Insulet Corporation | Insulin delivery system and methods with risk-based set points |
| WO2018058041A1 (en) | 2016-09-23 | 2018-03-29 | Insulet Corporation | Fluid delivery device with sensor |
| KR20180050946A (ko) * | 2016-11-07 | 2018-05-16 | 삼성전자주식회사 | 심혈관계 건강 상태 제공 장치 및 방법 |
| EP3500161A4 (en) | 2016-12-12 | 2020-01-08 | Bigfoot Biomedical, Inc. | ALARMS AND ALERTS FOR MEDICATION DELIVERY DEVICES AND RELATED SYSTEMS AND METHODS |
| WO2018132754A1 (en) | 2017-01-13 | 2018-07-19 | Mazlish Bryan | System and method for adjusting insulin delivery |
| US10610644B2 (en) | 2017-01-13 | 2020-04-07 | Bigfoot Biomedical, Inc. | Insulin delivery methods, systems and devices |
| US10758675B2 (en) | 2017-01-13 | 2020-09-01 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10500334B2 (en) | 2017-01-13 | 2019-12-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US11033682B2 (en) | 2017-01-13 | 2021-06-15 | Bigfoot Biomedical, Inc. | Insulin delivery methods, systems and devices |
| KR102515832B1 (ko) * | 2017-03-27 | 2023-03-29 | 삼성전자주식회사 | 글루코스 특징 추출 방법과, 글루코스 모니터링 장치 및 방법 |
| EP3381368A1 (en) * | 2017-03-27 | 2018-10-03 | Samsung Electronics Co., Ltd. | Method of enabling feature extraction for glucose monitoring using near-infrared (nir) spectroscopy |
| US11504034B2 (en) | 2017-07-27 | 2022-11-22 | Vita-Course Digital Technologies (Tsingtao) Co., Ltd. | Systems and methods for determining blood pressure of a subject |
| KR102487058B1 (ko) * | 2017-11-17 | 2023-01-09 | 삼성전자주식회사 | 생체정보 측정 장치 및 방법 |
| KR102715921B1 (ko) * | 2018-02-23 | 2024-10-10 | 삼성전자주식회사 | 혈중 성분의 농도 예측 장치 및 방법 |
| CN110186869B (zh) * | 2018-02-23 | 2023-08-15 | 三星电子株式会社 | 用于估计血液化合物浓度的装置和方法 |
| USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
| US11565043B2 (en) | 2018-05-04 | 2023-01-31 | Insulet Corporation | Safety constraints for a control algorithm based drug delivery system |
| CN112789070A (zh) | 2018-09-28 | 2021-05-11 | 英赛罗公司 | 人造胰腺系统的活动模式 |
| WO2020077223A1 (en) | 2018-10-11 | 2020-04-16 | Insulet Corporation | Event detection for drug delivery system |
| USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
| US11744491B2 (en) * | 2019-05-14 | 2023-09-05 | The Regents Of The University Of California | Noninvasive method and apparatus for peripheral assessment of vascular health |
| US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
| US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
| EP4069082B1 (en) | 2019-12-06 | 2024-06-05 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
| US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
| EP4088286A1 (en) | 2020-01-06 | 2022-11-16 | Insulet Corporation | Prediction of meal and/or exercise events based on persistent residuals |
| EP4100958A1 (en) | 2020-02-03 | 2022-12-14 | Insulet Corporation | Use of fuzzy logic in predicting user behavior affecting blood glucose concentration |
| US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
| US11986630B2 (en) | 2020-02-12 | 2024-05-21 | Insulet Corporation | Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk |
| US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
| US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
| US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
| US12121700B2 (en) | 2020-07-22 | 2024-10-22 | Insulet Corporation | Open-loop insulin delivery basal parameters based on insulin delivery records |
| US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
| WO2022072332A1 (en) | 2020-09-30 | 2022-04-07 | Insulet Corporation | Drug delivery device with integrated optical-based glucose monitor |
| WO2022072618A1 (en) | 2020-09-30 | 2022-04-07 | Insulet Corporation | Secure wireless communications between a glucose monitor and other devices |
| US11160925B1 (en) | 2021-01-29 | 2021-11-02 | Insulet Corporation | Automatic drug delivery system for delivery of a GLP-1 therapeutic |
| US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
| WO2022192482A1 (en) | 2021-03-10 | 2022-09-15 | Insulet Corporation | A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions |
| US12406760B2 (en) | 2021-06-07 | 2025-09-02 | Insulet Corporation | Exercise safety prediction based on physiological conditions |
| US11738144B2 (en) | 2021-09-27 | 2023-08-29 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
| US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
| EP4646726A1 (en) | 2023-01-06 | 2025-11-12 | Insulet Corporation | Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526568A (en) * | 1982-09-29 | 1985-07-02 | Miles Laboratories, Inc. | Diagnostic method and apparatus for clamping blood glucose concentration |
| US5178142A (en) | 1989-05-23 | 1993-01-12 | Vivascan Corporation | Electromagnetic method and apparatus to measure constituents of human or animal tissue |
| US5183042A (en) * | 1989-05-23 | 1993-02-02 | Vivascan Corporation | Electromagnetic method and apparatus to measure constituents of human or animal tissue |
| US5137023A (en) | 1990-04-19 | 1992-08-11 | Worcester Polytechnic Institute | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography |
| DE68902738T2 (de) * | 1989-05-23 | 1993-01-28 | Biosensors Technology Inc | Verfahren zur bestimmung mittels strahlungsabsorption von substanzen in absorbierenden und streuenden matrixmaterialien. |
| US4975581A (en) * | 1989-06-21 | 1990-12-04 | University Of New Mexico | Method of and apparatus for determining the similarity of a biological analyte from a model constructed from known biological fluids |
| US5039855A (en) * | 1990-03-05 | 1991-08-13 | Bran+Luebbe Analyzing Technologies, Inc. | Dual beam acousto-optic tunable spectrometer |
| US5120961A (en) | 1990-03-16 | 1992-06-09 | Infrared Fiber Systems, Inc. | High sensitivity acousto-optic tunable filter spectrometer |
| US5115133A (en) * | 1990-04-19 | 1992-05-19 | Inomet, Inc. | Testing of body fluid constituents through measuring light reflected from tympanic membrane |
| US5090418A (en) * | 1990-11-09 | 1992-02-25 | Del Mar Avionics | Method and apparatus for screening electrocardiographic (ECG) data |
| AU2245092A (en) * | 1991-12-31 | 1993-07-28 | Vivascan Corporation | Blood constituent determination based on differential spectral analysis |
| US5370114A (en) * | 1992-03-12 | 1994-12-06 | Wong; Jacob Y. | Non-invasive blood chemistry measurement by stimulated infrared relaxation emission |
| US6222189B1 (en) * | 1992-07-15 | 2001-04-24 | Optix, Lp | Methods of enhancing optical signals by mechanical manipulation in non-invasive testing |
| US5348003A (en) * | 1992-09-03 | 1994-09-20 | Sirraya, Inc. | Method and apparatus for chemical analysis |
| US6172743B1 (en) * | 1992-10-07 | 2001-01-09 | Chemtrix, Inc. | Technique for measuring a blood analyte by non-invasive spectrometry in living tissue |
| US5435309A (en) * | 1993-08-10 | 1995-07-25 | Thomas; Edward V. | Systematic wavelength selection for improved multivariate spectral analysis |
| WO1995006431A2 (en) | 1993-08-24 | 1995-03-09 | Robinson Mark R | A robust accurate non-invasive analyte monitor |
| US5459317A (en) * | 1994-02-14 | 1995-10-17 | Ohio University | Method and apparatus for non-invasive detection of physiological chemicals, particularly glucose |
| US5560356A (en) | 1994-02-23 | 1996-10-01 | Vitrophage, Inc. | Diagnostic system and method using an implanted reflective device |
| TW275570B (enExample) * | 1994-05-05 | 1996-05-11 | Boehringer Mannheim Gmbh | |
| US5477321A (en) * | 1994-08-31 | 1995-12-19 | Bayer Corporation | Dual beam tunable spectrometer |
| US5571401A (en) * | 1995-03-27 | 1996-11-05 | California Institute Of Technology | Sensor arrays for detecting analytes in fluids |
| SG38866A1 (en) * | 1995-07-31 | 1997-04-17 | Instrumentation Metrics Inc | Liquid correlation spectrometry |
| US5606164A (en) * | 1996-01-16 | 1997-02-25 | Boehringer Mannheim Corporation | Method and apparatus for biological fluid analyte concentration measurement using generalized distance outlier detection |
| US5655530A (en) * | 1995-08-09 | 1997-08-12 | Rio Grande Medical Technologies, Inc. | Method for non-invasive blood analyte measurement with improved optical interface |
| US5636633A (en) * | 1995-08-09 | 1997-06-10 | Rio Grande Medical Technologies, Inc. | Diffuse reflectance monitoring apparatus |
| US6174424B1 (en) * | 1995-11-20 | 2001-01-16 | Cirrex Corp. | Couplers for optical fibers |
| ATE209017T1 (de) * | 1996-02-05 | 2001-12-15 | Diasense Inc | Vorrichtung zur nicht-invasiven bestimmung von glukose |
| ATE346539T1 (de) * | 1996-07-19 | 2006-12-15 | Daedalus I Llc | Vorrichtung zur unblutigen bestimmung von blutwerten |
| EP1011426A1 (en) * | 1997-02-26 | 2000-06-28 | Diasense, Inc. | Individual calibration of blood glucose for supporting noninvasive self-monitoring blood glucose |
| TW352335B (en) * | 1997-03-25 | 1999-02-11 | Matsushita Electric Works Ltd | Method of determining a glucose concentration in a target by using near-infrared spectroscopy |
| JP3758823B2 (ja) | 1997-08-06 | 2006-03-22 | 倉敷紡績株式会社 | 生体の位置決め装置 |
| US6558351B1 (en) * | 1999-06-03 | 2003-05-06 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
| US5815277A (en) | 1997-06-20 | 1998-09-29 | The Board Of Trustees Of The Leland Stanford Junior Univesity | Deflecting light into resonant cavities for spectroscopy |
| GB2328279B (en) * | 1997-08-12 | 2001-10-10 | Abbott Lab | Optical glucose detector |
| US6070093A (en) * | 1997-12-02 | 2000-05-30 | Abbott Laboratories | Multiplex sensor and method of use |
| US6119026A (en) * | 1997-12-04 | 2000-09-12 | Hewlett-Packard Company | Radiation apparatus and method for analysis of analytes in sample |
| US6721582B2 (en) | 1999-04-06 | 2004-04-13 | Argose, Inc. | Non-invasive tissue glucose level monitoring |
| US6241663B1 (en) * | 1998-05-18 | 2001-06-05 | Abbott Laboratories | Method for improving non-invasive determination of the concentration of analytes in a biological sample |
| US6662030B2 (en) | 1998-05-18 | 2003-12-09 | Abbott Laboratories | Non-invasive sensor having controllable temperature feature |
| US6064897A (en) * | 1998-06-01 | 2000-05-16 | Abbott Laboratories | Sensor utilizing Raman spectroscopy for non-invasive monitoring of analytes in biological fluid and method of use |
| US6441388B1 (en) * | 1998-10-13 | 2002-08-27 | Rio Grande Medical Technologies, Inc. | Methods and apparatus for spectroscopic calibration model transfer |
| US6157041A (en) * | 1998-10-13 | 2000-12-05 | Rio Grande Medical Technologies, Inc. | Methods and apparatus for tailoring spectroscopic calibration models |
| JP2000186998A (ja) | 1998-12-22 | 2000-07-04 | Matsushita Electric Works Ltd | 生体スペクトル測定装置 |
| US6725073B1 (en) * | 1999-08-17 | 2004-04-20 | Board Of Regents, The University Of Texas System | Methods for noninvasive analyte sensing |
| IL135077A0 (en) * | 2000-03-15 | 2001-05-20 | Orsense Ltd | A probe for use in non-invasive measurements of blood related parameters |
| US6862091B2 (en) | 2001-04-11 | 2005-03-01 | Inlight Solutions, Inc. | Illumination device and method for spectroscopic analysis |
| ATE533398T1 (de) | 2001-08-02 | 2011-12-15 | Jonathan Gerlitz | Nicht-invasives blutzuckermessgerät |
| CA2418399A1 (en) | 2002-02-11 | 2003-08-11 | Bayer Healthcare, Llc | Non-invasive system for the determination of analytes in body fluids |
| EP1646312A1 (en) | 2003-07-09 | 2006-04-19 | Glucon Inc. | Wearable glucometer |
-
2003
- 2003-02-04 CA CA002418399A patent/CA2418399A1/en not_active Abandoned
- 2003-02-04 EP EP11178959A patent/EP2400288A1/en not_active Withdrawn
- 2003-02-04 AU AU2003200359A patent/AU2003200359A1/en not_active Abandoned
- 2003-02-04 EP EP03002185A patent/EP1335199A1/en not_active Withdrawn
- 2003-02-10 JP JP2003032015A patent/JP4476552B2/ja not_active Expired - Lifetime
- 2003-02-11 US US10/361,895 patent/US7299079B2/en not_active Expired - Lifetime
-
2007
- 2007-10-10 US US11/973,790 patent/US8452359B2/en active Active
- 2007-10-12 US US11/974,477 patent/US8160666B2/en active Active
-
2013
- 2013-04-26 US US13/871,116 patent/US9554735B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114206215A (zh) * | 2019-06-12 | 2022-03-18 | 汽车交通安全联合公司 | 用于车辆驾驶员中分析物的非侵入性测量的系统 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003200359A1 (en) | 2003-08-28 |
| US20040092804A1 (en) | 2004-05-13 |
| EP2400288A1 (en) | 2011-12-28 |
| EP1335199A1 (en) | 2003-08-13 |
| US20080045820A1 (en) | 2008-02-21 |
| JP2003235832A (ja) | 2003-08-26 |
| US7299079B2 (en) | 2007-11-20 |
| US8160666B2 (en) | 2012-04-17 |
| US20080045821A1 (en) | 2008-02-21 |
| US9554735B2 (en) | 2017-01-31 |
| US20130261406A1 (en) | 2013-10-03 |
| US8452359B2 (en) | 2013-05-28 |
| JP4476552B2 (ja) | 2010-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8452359B2 (en) | Method for building an algorithm for converting spectral information | |
| US8180422B2 (en) | Non-invasive system and method for measuring an analyte in the body | |
| US7254432B2 (en) | Method and device for non-invasive measurements of blood parameters | |
| US5553615A (en) | Method and apparatus for noninvasive prediction of hematocrit | |
| US7761126B2 (en) | Apparatus for non-invasive determination of direction and rate of change of an analyte | |
| US5460177A (en) | Method for non-invasive measurement of concentration of analytes in blood using continuous spectrum radiation | |
| US5372135A (en) | Blood constituent determination based on differential spectral analysis | |
| US5383452A (en) | Method, apparatus and procedure for non-invasive monitoring blood glucose by measuring the polarization ratio of blood luminescence | |
| EP0919180B1 (en) | Method and apparatus for noninvasive measurement of blood glucose by photoacoustics | |
| CA2310468A1 (en) | Multiplex sensor and method of use | |
| EP1885235A1 (en) | Improved method for spectrophotometric blood oxygenation monitoring | |
| WO1999043255A1 (en) | Near infrared-transmission spectroscopy of tongue tissue | |
| US20040225206A1 (en) | Non-invasive analyte measurement device having increased signal to noise ratios | |
| JP3694291B2 (ja) | 血糖値の無侵襲測定装置 | |
| JP2000131322A (ja) | グルコース濃度の定量方法及びその装置 | |
| Olakanmi et al. | NIBG: an efficient near-infrared spectroscopy-based device for tele-monitoring blood glucose level of diabetes outpatients in an e-health system | |
| CA3238455A1 (en) | Calibration method and system | |
| Shih et al. | Introduction to spectroscopy for noninvasive glucose sensing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 20120423 |